Athina Pangalu

Athina Pangalu

Auto-generated profile, based on publicly available information

Athina Pangalu

Clinical Neuroscience Center (C.H.B.v.N., M.S., M.R.G., M.H., T.P., V.S., J.B., M.P., A.P., M.K., S.W., Z.K., A.R.L., L.R., J.F.), University Hospital of Zürich, University of Zürich, Switzerland

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2018 in Magnetic Resonance Imaging
Verified
Journal Article
Closed access
CNChristiaan Hendrik Bas van Niftrik
Christiaan Hendrik Bas van Niftrik
MPMarco Piccirelli
Marco Piccirelli
OBOliver Bozinov
Oliver Bozinov
NMNicolai Maldaner
Nicolai Maldaner
CSCatherine Strittmatter
Catherine Strittmatter
JFJorn Fierstra
Jorn Fierstra

1 March 2024 in Stroke
Verified
Journal Article
Closed access
CNChristiaan Hendrik Bas van Niftrik
Christiaan Hendrik Bas van Niftrik
Martina SebökMartina Sebök
Martina Sebök
MGMenno R. Germans
Menno R. Germans
MHMatthias Halter
Matthias Halter
TPThomas Pokorny
Thomas Pokorny
JFJorn Fierstra
Jorn Fierstra
BACKGROUND: Impaired cerebrovascular reactivity (CVR) has been correlated with recurrent ischemic stroke. However, for clinical purposes, most CVR techniques are rather complex, time-consuming, and lack validation for quantitative measurements. The recent adaptation of a standardized hypercapnic stimulus in combination with a blood-oxygenation-level-dependent (BOLD) magnetic resonance imaging signal as a surrogate for cerebral blood flow offers a potential universally comparable CVR assessment. We investigated the association between impaired BOLD-CVR and risk for recurrent ischemic events. METHODS: We conducted a retrospective analysis of patients with symptomatic cerebrovascular large vessel disease who had undergone a prospective hypercapnic-challenged BOLD-CVR protocol at a single tertiary stroke referral center between June 2014 and April 2020. These patients were followed up for recurrent acute ischemic events for up to 3 years. BOLD-CVR (%BOLD signal change per mm Hg CO 2 ) was calculated on a voxel-by-voxel basis. Impaired BOLD-CVR of the affected (ipsilateral to the vascular pathology) hemisphere was defined as an average BOLD-CVR, falling 2 SD below the mean BOLD-CVR of the right hemisphere in a healthy age-matched reference cohort (n=20). Using a multivariate Cox proportional hazards model, the association between impaired BOLD-CVR and ischemic stroke recurrence was assessed and Kaplan-Meier survival curves to visualize the acute ischemic stroke event rate. RESULTS: Of 130 eligible patients, 28 experienced recurrent strokes (median, 85 days, interquartile range, 5–166 days). Risk factors associated with an increased recurrent stroke rate included impaired BOLD-CVR, a history of atrial fibrillation, and heart insufficiency. After adjusting for sex, age group, and atrial fibrillation, impaired BOLD-CVR exhibited a hazard ratio of 10.73 (95% CI, 4.14–27.81; P <0.001) for recurrent ischemic stroke. CONCLUSIONS: Among patients with symptomatic cerebrovascular large vessel disease, those exhibiting impaired BOLD-CVR in the affected hemisphere had a 10.7-fold higher risk of recurrent ischemic stroke events compared with individuals with nonimpaired BOLD-CVR.

1 December 2011 in Journal of Neuro-Ophthalmology
Verified
Journal Article
Open access
GTGhislaine Traber
Ghislaine Traber
MBMatthias R. Baumgartner
Matthias R. Baumgartner
USUrs Schwarz
Urs Schwarz
APAthina Pangalu
Athina Pangalu
MDMarc Y. Donath
Marc Y. Donath
KLKlara Landau
Klara Landau
A 23-year-old woman known to have methylmalonic acidemia (MMA) since birth suffered bilateral visual loss within 5 days. Multiple sclerosis, Leber hereditary optic neuropathy, vasculitis, infections (in particular treponema), and vitamin deficiency were ruled out. The optic nerve head changed from normal in appearance to atrophic. Treatment attempts with high-dose intravenous steroids and coenzyme Q10 combined with vitamin E were ineffective. The patient's underlying disease was metabolically well controlled by strict diet and carnitine supplementation. Toxic damage of both optic nerves due to MMA is the most likely mechanism. MRI showed moderate enhancement of both optic nerves. To our knowledge, this is the first report of a morphological correlate on MRI.

1 January 2021 in Neuro-Oncology Advances
Verified
Journal Article
Open access
PDF file
Martina SebökMartina Sebök
Martina Sebök
CNChristiaan Hendrik Bas van Niftrik
Christiaan Hendrik Bas van Niftrik
GMGiovanni Muscas
Giovanni Muscas
APAthina Pangalu
Athina Pangalu
KSKatharina Seystahl
Katharina Seystahl
JFJorn Fierstra
Jorn Fierstra
Diffuse gliomas exhibit diffuse infiltrative growth, often beyond the magnetic resonance imaging (MRI)-detectable tumor lesion. Within this lesion, hypermetabolism and impaired cerebrovascular reactivity (CVR) are found, but its exact distribution pattern into the peritumoral environment is unknown. Our aim was to better characterize the extent of diffuse glioma tissue infiltration, beyond the visible lesion (ie, beyond the T1-contrast-enhancing lesion and/or T2/FLAIR-defined tumor border), with metabolic positron emission tomography (PET), and functional MRI CVR (blood oxygenation-level-dependent CVR [BOLD-CVR]) mapping. From a prospective glioma database, 18 subjects (19 datasets) with diffuse glioma (n = 2 with anaplastic astrocytoma, n = 10 with anaplastic oligodendroglioma, and n = 7 with glioblastoma) underwent a BOLD-CVR and metabolic PET study between February 2016 and September 2019, 7 of them at primary diagnosis and 12 at tumor recurrence. In addition, 19 matched healthy controls underwent an identical BOLD-CVR study. The tumor lesion was defined using high-resolution anatomical MRI. Volumes of interest starting from the tumor lesion outward up to 30 mm were created for a detailed peritumoral PET and BOLD-CVR tissue analysis. Student’s t test was used for statistical analysis. Patients with diffuse glioma exhibit impaired BOLD-CVR 12 mm beyond the tumor lesion (P = .02) with normalization of BOLD-CVR values after 24 mm. Metabolic PET shows a difference between the affected and contralateral hemisphere of 6 mm (P = .05) with PET values normalization after 12 mm. We demonstrate hypermetabolism and impaired CVR beyond the standard MRI-defined tumor border, suggesting active tumor infiltration in the peritumoral environment.

19 December 2023 in Journal of the American Heart Association
Verified
Journal Article
Open access
Martina SebökMartina Sebök
Martina Sebök
FWFrank van der Wouden
Frank van der Wouden
CMCäcilia Mader
Cäcilia Mader
APAthina Pangalu
Athina Pangalu
VTValerie Treyer
Valerie Treyer
CNChristiaan Hendrik Bas van Niftrik
Christiaan Hendrik Bas van Niftrik
Background: Staging of hemodynamic failure (HF) in symptomatic patients with cerebrovascular steno‐occlusive disease is required to assess the risk of ischemic stroke. Since the gold standard positron emission tomography‐based perfusion reserve is unsuitable as a routine clinical imaging tool, blood oxygenation level–dependent cerebrovascular reactivity (BOLD‐CVR) with CO 2 is a promising surrogate imaging approach. We investigated the accuracy of standardized BOLD‐CVR to classify the extent of HF. Methods and Results: Patients with symptomatic unilateral cerebrovascular steno‐occlusive disease, who underwent both an acetazolamide challenge ( 15 O‐)H 2 O‐positron emission tomography and BOLD‐CVR examination, were included. HF staging of vascular territories was assessed using qualitative inspection of the positron emission tomography perfusion reserve images. The optimum BOLD‐CVR cutoff points between HF stages 0–1–2 were determined by comparing the quantitative BOLD‐CVR data to the qualitative ( 15 O‐)H 2 O‐positron emission tomography classification using the 3‐dimensional accuracy index to the randomly assigned training and test data sets with the following determination of a single cutoff for clinical application. In the 2‐case scenario, classifying data points as HF 0 or 1–2 and HF 0–1 or 2, BOLD‐CVR showed an accuracy of >0.7 for all vascular territories for HF 1 and HF 2 cutoff points. In particular, the middle cerebral artery territory had an accuracy of 0.79 for HF 1 and 0.83 for HF 2, whereas the anterior cerebral artery had an accuracy of 0.78 for HF 1 and 0.82 for HF 2. Conclusions: Standardized and clinically accessible BOLD‐CVR examinations harbor sufficient data to provide specific cerebrovascular reactivity cutoff points for HF staging across individual vascular territories in symptomatic patients with unilateral cerebrovascular steno‐occlusive disease.

20 December 2021 in Diagnostics
Verified
Journal Article
Open access
PDF file
JGJeanne Martine Gunzinger
Jeanne Martine Gunzinger
BIBurbuqe Ibrahimi
Burbuqe Ibrahimi
JBJoel Baur
Joel Baur
MWMaximilian Robert Justus Wiest
Maximilian Robert Justus Wiest
MPMarco Piccirelli
Marco Piccirelli
SZSandrine Anne Zweifel
Sandrine Anne Zweifel
Transcatheter aortic valve implantation (TAVI) is an alternative to open heart surgery in the treatment of symptomatic aortic valve stenosis, which is often the treatment of choice in elderly and frail patients. It carries a risk of embolic complications in the whole cerebral vascular bed, which includes the retinal vasculature. The main objective was the evaluation of retinal emboli visible on optical coherence tomography angiography (OCTA) following TAVI. This is a prospective, single center, observational study enrolling consecutive patients over two years. Patients were assessed pre- and post-TAVI. Twenty-eight patients were included in the final analysis, 82.1% were male, median age was 79.5 (range 52–88), median BCVA was 82.5 letters (range 75–93). Eight patients (28.6%) presented new capillary dropout lesions in their post-TAVI OCTA scans. There was no statistically significant change in BCVA. Quantitative analysis of macular or peripapillary OCTA parameters did not show any statistically significant difference in pre- and post-intervention. In conclusion, capillary dropout lesions could frequently be found in patients after TAVI. Quantitative measurements of macular and peripapillary flow remained stable, possibly indicating effective ocular blood flow regulation within the range of left ventricular ejection fraction in our cohort.